Can finger-prick sampling replace venous sampling? A - - PowerPoint PPT Presentation

can finger prick sampling replace venous sampling a
SMART_READER_LITE
LIVE PREVIEW

Can finger-prick sampling replace venous sampling? A - - PowerPoint PPT Presentation

Can finger-prick sampling replace venous sampling? A pharmacokinetic perspective. Bart Remmerie, Chem. Eng. Clinical Pharmacology Bart Rem m erie Outline Pharmacokinetic aspects related to blood PK Cases Pharmacokinetic aspects


slide-1
SLIDE 1

Bart Rem m erie

Can finger-prick sampling replace venous sampling? A pharmacokinetic perspective.

Bart Remmerie, Chem. Eng. Clinical Pharmacology

slide-2
SLIDE 2

Bart Rem m erie

Outline

  • Pharmacokinetic aspects related to blood PK
  • Cases
  • Pharmacokinetic aspects related to fingerstick sampling
  • Conclusions

1

slide-3
SLIDE 3

Bart Rem m erie

Pharmacokinetic considerations as to when to use dried blood spot sampling

  • M. Rowland & G. Emmons, Bioanalysis 2 (11), 1791-1796, 2010

u * plasma u

f C C =

]

u blood u

R x H f H

  • 1

C C + = /[

W hole Blood ( unbound) concentration is sensitive to

  • Hematocrit H
  • Unbound fraction fu in plasma
  • Ratio R of blood cell concentration-to-unbound concentration in

plasma water, which can change, e.g. due to saturation of binding affinity in red blood cells, binding to platelets, …

2

The unbound concentration as driving force for pharmacokinetics and pharmacodynamics

slide-4
SLIDE 4

Bart Rem m erie

Application of DBS-LC-MS/MS to Geno- and Phenotyping of P450 enzymes.

De Boer T, Wieling J, et al. Biomed. Chromatogr. 25 (10): 1112-1123, 2011

3

Conclusion DB: DBS suitable for PK analysis and Genotyping Conclusion BR: DBS overestim ates reference procedure; Finger puncture blood concentration > venous blood concentration, m ay be adequate for TDM. Single Dose, Healthy Volunteers ( N= 1 2 ) Venous blood ( DBS, blood, plasm a) Finger puncture ( DBS)

slide-5
SLIDE 5

Bart Rem m erie

Internal case 1: study design

  • Objective: evaluate feasibility finger-prick derived blood for TDM
  • Parallel-group (N= 5)
  • Single dose, N= 12 healthy volunteers per treatment group
  • Extensive PK sampling (total < 122 mL):

– Venous blood and plasma (total: 3 mL/sample) – Fingerstick blood and plasma (total: 0.5 mL/sample)

4

slide-6
SLIDE 6

Bart Rem m erie

Compound O

5

Conclusion: Fingerstick plasm a overestim ates venous plasm a for com pound O

1 2 3 4 5 6 7 8 20 40 60 80 100 120 Time (hours)

Fingerstick plasma Venous plasma

slide-7
SLIDE 7

Bart Rem m erie

Ratio fingerstick/ venous plasma versus time

6

Conclusion: Fingerstick plasm a overestim ates venous plasm a for com pound O

slide-8
SLIDE 8

Bart Rem m erie

Ratio fingerstick/ venous plasma versus time

7

Conclusion: Fingerstick plasm a = venous plasm a for com pounds A and D ( except for first hours?) ….

slide-9
SLIDE 9

Bart Rem m erie

Ratio fingerstick/ venous plasma versus time

8

… how ever, fingerstick plasm a m ay overestim ate venous plasm a in som e individuals

slide-10
SLIDE 10

Bart Rem m erie

Case 2

  • Single Dose, cross-over study (25, 50, 100 mg dose), fasted
  • Matrices collected:

– Venous plasma (LCMS) – Venous blood (LCMS/DBS) – Fingerprick blood (DBS)

9

  • Fabs: 75%
  • Vd: 2.6 and 2.9 L/kg
  • PPB: 20%
  • Tmax: 12h ; T1/2: 9h
slide-11
SLIDE 11

Bart Rem m erie

Case 2 (highest dose)

20 40 60 80 100 120 5 10 15 20 25 30 35 40 45 50 Time (Hours)

Plasma Whole Blood DBS Venous DBS Capillary

Conclusion 1 : DBS overestim ates reference m ethod Conclusion 2 : Fingerstick blood > venous blood concentrations

slide-12
SLIDE 12

Bart Rem m erie

Case 2: ratio fingerstick/venous versus time

11

slide-13
SLIDE 13

Bart Rem m erie

Case 3

  • Single Dose, parent drug and metabolite measured
  • Matrices collected:

– Venous plasma – Fingerstick plasma – DBS (fingerstick)

12

  • Fabs: 52%
  • Vd: 0.34 L/kg
  • PPB: 96.3%
  • Tmax: 2-5h ; T1/2: 1.3h
slide-14
SLIDE 14

Bart Rem m erie

Case 3 (parent drug)

13

Conclusion: Fingerstick plasm a > venous plasm a concentrations

slide-15
SLIDE 15

Bart Rem m erie

Case 3: metabolite

14

Conclusion: Fingerstick plasm a > venous plasm a concentrations

slide-16
SLIDE 16

Bart Rem m erie

  • W. L. Chiou. The phenomenon and rationale of

Marked Dependence of Drug Concentration on Blood sampling Site. Clin Pharm. 17 (3) 1989

  • 40+ examples
  • Mechanistic hypothesis

– f= 1-(0.693* R/ (t 1/ 2* Q)) with, – f= arterial/ venous concentration ratio – R= apparent partition coefficient tissue/ venous blood – Q: blood flow

  • “… virtually all compounds of clinical

interest… will be more or less affected by the sampling site chosen.”

  • “… marked arteriovenous differences can

exist for hrs or days… ”

  • Initial distribution vs. elimination phase

15

slide-17
SLIDE 17

Bart Rem m erie

Potential reasons for dissociation

  • Physiological

– Initial contamination with interstitial fluid? – Effect of stimulation? – Location distinct from arm? – Capillary blood more reflective

  • f arterial blood?

– Extraction (Cl/ V) of drug by surrounding sampling tissue? – Effect of blood flow?

  • Drug-related

– High (first-pass) extraction? – High Vd/ R? – Small, lipophilic molecules, neutral at pH= 7.4? – Related to duration of absorption? – Multi-factorial?

16

slide-18
SLIDE 18

Bart Rem m erie

Final comments & conclusions

  • Plasma-based PK may be more directly related to PD
  • Fingerstick based drug levels can overestimate venous plasma levels
  • Bias especially observed after SD (less at SS?)
  • Adequacy depends on objective (S.D., M.D., TDM)
  • What about PD parameters, biomarkers?
  • Consistent data across/between studies requires consistent

methodology

  • Evaluate consequences of methodological change for project

17

slide-19
SLIDE 19

Bart Rem m erie

Acknowledgements

  • Achiel Van Peer
  • Joris Vandenbossche
  • Jeike Biewenga
  • All bioanalytical colleagues involved

18

slide-20
SLIDE 20

Bart Rem m erie

Q&A

19